Market Snapshot and Corporate Update for C‑Rad AB (Class B Shares)

Trading Performance

During a 24‑hour period ending at 12:15 PM Central Europe on Friday 23 October, C‑Rad Class B (CRAD‑B.ST) experienced a modest uptick, rising 1.06 % to trade at approximately SEK 21 on major exchanges. The share count in circulation stands at 34.1 million, while the company’s market capitalization is currently SEK 753 million. In the last 24 hours, trading volume reached roughly SEK 313.3 k, indicating a relatively liquid but subdued trading environment.

Historically, the share has exhibited a downward trajectory, falling 15.59 % since the end of the previous month. The 200‑day simple moving average sits at SEK 32.16, suggesting a significant discount to the longer‑term trend. Over the past year, the highest price reached SEK 39.4 on 25 June 2026, while the low fell to SEK 24.6 on 30 April 2026.

Third‑Quarter Financial Overview

C‑Rad AB disclosed a challenging third quarter, with both order intake and revenue declining relative to the same period last year. The downturn was most pronounced in the EMEA and APAC regions, whereas the Americas showed a modest rebound in service revenue. Notwithstanding the headline decline, gross and operating margins remained comparatively healthy, largely due to a higher proportion of service income and disciplined cost control measures.

The company reported a significant write‑off of its order backlog following the cancellation of a large U.S. order. Despite this setback, the remaining backlog remains substantial, underscoring the firm’s ongoing pipeline. Management highlighted the imperative to improve commercial conversion rates and to strengthen recurring revenue streams from its established installed base.

In line with its three‑year transformation plan, C‑Rad continues to invest in product development and strategic partnerships, aiming to deliver customer‑oriented solutions and expand its market presence. The firm also confirmed a share‑repurchase programme for its Class B shares, signalling confidence in the long‑term value proposition.

Comparative Peer Activity

  • Troax (TROAX.ST): Up 1.5 %, trading at SEK 144.4; market cap SEK 851.1 million; P/E = 328.23.
  • Hexatronic (HTRO.ST): Up 0.62 %, trading at SEK 43.18; market cap SEK 822.8 million; P/E = 202.89.
  • Devyser Diagnostics (DVYSR.ST): Flat, trading at SEK 50.7; market cap SEK 852.9 million; P/E = 55.06.
  • Acconeer (ACCON.ST): Up 1.45 %, trading at SEK 10.8; market cap SEK 849.7 million. Acconeer delivered record sales of half‑million sensors and achieved its fifth consecutive quarter of record revenue growth, with a sales margin improving to around sixty per cent. Operating losses widened, reflected in a negative EBITDA and a negative profit after tax for the quarter, although management expects growth to continue into the next quarter.
  • Saltx (SALT‑B.ST): Up 1.81 %, trading at SEK 3.98; market cap SEK 860.5 million.

Company Profile

C‑Rad AB is a Swedish‑based health‑care equipment and supplies company founded in 2004 and headquartered in Uppsala. The company specializes in the development, manufacturing, and sale of systems used in radiation therapy for cancer treatment worldwide. It operates through two segments: Positioning and Imaging. C‑Rad’s product portfolio includes optical surface scanning systems, surface image‑guided radiation therapy solutions, 4D SIGRT solutions, advanced particle therapy solutions, enhanced positioning solutions for tomotherapy, laser positioning products, and an X‑ray detector optimized for electronic portal imaging devices.

Beyond hardware, C‑Rad offers installation, application training, and after‑sales services, and maintains a partnership agreement with XECAN to develop products that advance patient positioning and resource management in radiation therapy. The firm’s focus remains on delivering innovative solutions that improve patient outcomes and operational efficiency in oncology care.

The information provided reflects the most recent publicly available data as of 23 October 2026 and is intended for informational purposes only.